4.4Impact Factor
8.8CiteScore
21 daysTime to First Decision

Cancers, Volume 2, Issue 1

March 2010 - 13 articles

Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
You may sign up for email alerts to receive table of contents of newly released issues.
PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (13)

Select all

Review

12 Citations

12,985 Views

11 Pages

Oxidative Stress and Exhaled Breath Analysis: A Promising Tool for Detection of Lung Cancer

Hiang Ping Chan,
Craig Lewis and
Paul S. Thomas

Cancers2010, 2(1), 32-42;https://doi.org/10.3390/cancers2010032

8 February 2010

Lung cancer is one of the few neoplasia in which the principal aetiology is known, with cigarette smoke donating a considerable oxidative burden to the lungs. This may be part of the aetiology of lung cancer, but the neoplastic process is also associ...

Full Article

Article

11 Citations

13,151 Views

12 Pages

Number of Axillary Lymph Node Metastases Determined by Preoperative Ultrasound is Related to Prognosis in Patients with Breast Cancer

Yuko Kijima,
Heiji Yoshinaka,
Munetsugu Hirata,
Tadao Mizoguchi,
Sumiya Ishigami,
Akihiro Nakajo,
Hideo Arima,
Shinichi Ueno and
Shoji Natsugoe

Cancers2010, 2(1), 20-31;https://doi.org/10.3390/cancers2010020

4 February 2010

Objective: To analyze the impact on prognosis of the number of axillary lymph node metastases (LNM) detected by ultrasound (US) in patients with breast cancer. Methods: One-to-one comparison of LNM was performed between the ultrasound and histologic...

Full Article

Review

5 Citations

10,609 Views

19 Pages

Novel Combinations for the Treatment of Metastatic Breast Cancer

Linda T. Vahdat

Cancers2010, 2(1), 1-19;https://doi.org/10.3390/cancers2010001

14 January 2010

Anthracyclines and taxanes represent the mainstay of first-line cytotoxic therapy for metastatic breast cancer (MBC), but most patients eventually develop resistance to these agents. Consequently, alternative combinations for MBC therapy are the subj...

Full Article

of 2

Get Alerted

Add your email address to receive forthcoming issues of this journal.

Cancers - ISSN 2072-6694

Imprint

Download Flyer